The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Kinetic characterisation of ene-diol-based inhibitors of alpha-amylase.EBI
University of Canterbury
Synthesis and evaluation of tetrahedral intermediate mimic inhibitors of 3-deoxy-d-manno-octulosonate 8-phosphate synthase.EBI
University of Canterbury
Molecular modeling: a search for a calpain inhibitor as a new treatment for cataractogenesis.EBI
University of Canterbury
Synthesis and evaluation of dual site inhibitors of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase.EBI
University of Canterbury
Evaluation of 4'-substituted bicyclic pyridones as non-steroidal inhibitors of steroid 5alpha-reductase.EBI
University of Canterbury
Exploring the roles of the Cdc2-like kinases in cancers.EBI
University of Canterbury
Alpha-ketoester-based photobiological switches: synthesis, peptide chain extension and assay against alpha-chymotrypsin.EBI
University of Canterbury
Simple bi- and tricyclic inhibitors of human steroid 5alpha-reductase.EBI
University of Canterbury
Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereofBDB
President and Fellows of Harvard College
Synthesis and identification of [1,2,4]thiadiazole derivatives as a new series of potent and orally active dual agonists of peroxisome proliferator-activated receptors alpha and delta.BDB
Johnson & Johnson Pharmaceutical